secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0001493152-23-042954
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve 336,667 share increase to Lixte's 2020 Stock Incentive Plan
--------------------------------------------------------------------------------

- At Nov 27 2023 annual meeting, shareholders voted to amend the 2020 Stock Incentive Plan, increasing authorized shares by 336,667 to 750,000.
- All five director nominees elected with votes ranging from 856,934 to 905,489 for; broker non-votes 559,164.
- Ratification of Weinberg & Company as auditor for FY2023 passed with 1,433,849 for, 40,266 against.
- Stock Plan amendment approved: 854,971 for, 60,023 against, 559,164 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315223042954/0001493152-23-042954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315223042954/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-042954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer